BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Swartz RD. Idiopathic Retroperitoneal Fibrosis: A Review of the Pathogenesis and Approaches to Treatment. American Journal of Kidney Diseases 2009;54:546-53. [DOI: 10.1053/j.ajkd.2009.04.019] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Doersch KM, Barnett D, Chase A, Johnston D, Gabrielsen JS. The contribution of the immune system to genitourinary fibrosis. Exp Biol Med (Maywood). [DOI: 10.1177/15353702221090872] [Reference Citation Analysis]
2 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2022. [DOI: 10.1007/978-3-642-41168-7_112-2] [Reference Citation Analysis]
3 Ring NAR, Volpe MC, Stepišnik T, Mamolo MG, Panov P, Kocev D, Vodret S, Fortuna S, Calabretti A, Rehman M, Colliva A, Marchesan P, Camparini L, Marcuzzo T, Bussani R, Scarabellotto S, Confalonieri M, Pham TX, Ligresti G, Caporarello N, Loffredo FS, Zampieri D, Džeroski S, Zacchigna S. Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation. Cell Death Dis 2021;13:2. [PMID: 34916483 DOI: 10.1038/s41419-021-04439-4] [Reference Citation Analysis]
4 Khalil S, Selvarajah N, Solanki S, Neiman-Hart H, Dregansky G. Unique Presentation of Idiopathic Retroperitoneal Fibrosis in a Primary Care Setting. Cureus 2021;13:e18429. [PMID: 34692257 DOI: 10.7759/cureus.18429] [Reference Citation Analysis]
5 Santiago J, Swartz R, Marder W, Daignault-Newton S, Malaeb B, Wolf JS Jr, Ambani S. Including Medical Management in the Urologic Approach to Idiopathic Retroperitoneal Fibrosis. Urology 2021;152:167-72. [PMID: 33716037 DOI: 10.1016/j.urology.2021.03.002] [Reference Citation Analysis]
6 Peisen F, Thaiss WM, Ekert K, Horger M, Amend B, Bedke J, Nikolaou K, Kaufmann S. Retroperitoneal Fibrosis and its Differential Diagnoses: The Role of Radiological Imaging. Rofo 2020;192:929-36. [DOI: 10.1055/a-1181-9205] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
7 Dreger NM, Degener S, Roth S, Ahmad-Nejad P, Kamper L, Müller E, von Rundstedt FC, Brandt AS. Impact of CYP2D6 Polymorphisms on Tamoxifen Treatment in Patients With Retroperitoneal Fibrosis: A First Step Towards Tailored Therapy? Urology 2020;137:84-90. [PMID: 31877313 DOI: 10.1016/j.urology.2019.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Shakir MKM, Hoang TD, Johnson JT, Mai VQ. Supraphysiological doses of glucocorticoids induce remission in a patient with retroperitoneal fibrosis but no effect on the course of Hashimoto’s thyroiditis: a discordant mode of action. Modern Rheumatology Case Reports 2019;3:172-178. [DOI: 10.1080/24725625.2019.1622859] [Reference Citation Analysis]
9 Raffiotta F, da Silva Escoli R, Quaglini S, Rognoni C, Sacchi L, Binda V, Messa P, Moroni G. Idiopathic Retroperitoneal Fibrosis: Long-term Risk and Predictors of Relapse. Am J Kidney Dis 2019;74:742-50. [PMID: 31204195 DOI: 10.1053/j.ajkd.2019.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
10 Rehman M, Vodret S, Braga L, Guarnaccia C, Celsi F, Rossetti G, Martinelli V, Battini T, Long C, Vukusic K, Kocijan T, Collesi C, Ring N, Skoko N, Giacca M, Del Sal G, Confalonieri M, Raspa M, Marcello A, Myers MP, Crovella S, Carloni P, Zacchigna S. High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight 2019;4:123987. [PMID: 30996132 DOI: 10.1172/jci.insight.123987] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
11 Yan P, Tang H, Chen X, Ji S, Jin W, Zhang J, Shen J, Deng H, Zhao X, Shen Q, Huang H. Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation. Biosci Rep 2018;38:BSR20180240. [PMID: 30061174 DOI: 10.1042/BSR20180240] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
12 Cohan RH, Shampain KL, Francis IR, Davenport MS, Stuart Wolf J, Marder W, Swartz RD. Imaging appearance of fibrosing diseases of the retroperitoneum: can a definitive diagnosis be made? Abdom Radiol (NY) 2018;43:1204-14. [PMID: 28849414 DOI: 10.1007/s00261-017-1282-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Brandt AS, Dreger NM, Müller E, Kukuk S, Roth S. Neue (und alte) Aspekte der retroperitonealen Fibrose. Urologe 2017;56:887-94. [DOI: 10.1007/s00120-017-0428-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Rossi GM, Rocco R, Accorsi Buttini E, Marvisi C, Vaglio A. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med 2017;12:287-99. [DOI: 10.1007/s11739-016-1599-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
15 Laroche AS, Bell RZ, Bezzaoucha S, Földes E, Lamarche C, Vallée M. Retroperitoneal fibrosis: retrospective descriptive study on clinical features and management. Res Rep Urol 2016;8:175-9. [PMID: 27822461 DOI: 10.2147/RRU.S115448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
16 Brandt AS, Kukuk S, Dreger NM, Müller E, Roth S. Diagnostik und Therapie der retroperitonealen Fibrose. Urologe 2016;55:732-40. [DOI: 10.1007/s00120-016-0081-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
17 Strickland FM, Patel D, Khanna D, Somers E, Robida AM, Pihalja M, Swartz R, Marder W, Richardson B. Characterisation of an epigenetically altered CD4(+) CD28(+) Kir(+) T cell subset in autoimmune rheumatic diseases by multiparameter flow cytometry. Lupus Sci Med 2016;3:e000147. [PMID: 27099767 DOI: 10.1136/lupus-2016-000147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
18 Segreto F, Carotti S, Tosi D, Pendolino AL, Marangi GF, Morini S, Persichetti P. Toll-Like Receptor 4 Expression in Human Breast Implant Capsules: Localization and Correlation with Estrogen Receptors. Plastic and Reconstructive Surgery 2016;137:792-8. [DOI: 10.1097/01.prs.0000479941.42174.f1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
19 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2016. [DOI: 10.1007/978-3-642-39940-4_112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Khalil F, Ouslim H, Mhanna T, Barki A. Extensive primary retroperitoneal fibrosis (Ormond's disease) with common bile duct and ureteral obstruction: A rare case report. Int J Surg Case Rep 2015;13:5-7. [PMID: 26074483 DOI: 10.1016/j.ijscr.2015.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Swartz RD. Retroperitoneal Fibrosis and Asbestosis—A Plausible Association? American Journal of Kidney Diseases 2015;65:378-80. [DOI: 10.1053/j.ajkd.2014.09.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
22 Mishra K, Zargar H, Tarplin S, Ramanathan R, Stein RJ. Idiopathic retroperitoneal fibrosis. J Urol. 2015;193:1657-1658. [PMID: 25659660 DOI: 10.1016/j.juro.2015.01.101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 Brandt AS, Goedde D, Kamper L, Haage P, Störkel S, Roth S. Retroperitoneale Fibrose (Morbus Ormond). Die Urologie 2015. [DOI: 10.1007/978-3-642-41168-7_112-1] [Reference Citation Analysis]
24 Brandt A, Kukuk S, Dreger N, Müller E, Roth S. Therapie der retroperitonealen Fibrose: Funktionelle Behandlungsergebnisse. Urologe 2015;54:62-9. [DOI: 10.1007/s00120-014-3712-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Gaertner S, Cordeanu EM, Mirea C, Stephan D. [Retroperitoneal fibrosis]. Presse Med 2014;43:1021-3. [PMID: 24863664 DOI: 10.1016/j.lpm.2014.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Quaia E, De Paoli L, Martingano P, Cavallaro M. Obstructive Uropathy, Pyonephrosis, and Reflux Nephropathy in Adults. Radiological Imaging of the Kidney 2014. [DOI: 10.1007/978-3-642-54047-9_14] [Reference Citation Analysis]
27 Kabbani A. M. Ormond. Urology at a Glance 2014. [DOI: 10.1007/978-3-642-54859-8_67] [Reference Citation Analysis]
28 Francklyn MM, Borgatia AD, Elombila M, Reddy AG, Tareq K. Retroperitoneal fibrosis. Exceptional cause of renal artery thrombosis with secondary hypertension. A case from University Mohamed V, CheikhZaid Hospital, Rabat, March 2013. J Cardiol Cases 2014;9:26-8. [PMID: 30546777 DOI: 10.1016/j.jccase.2013.09.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Persichetti P, Segreto F, Carotti S, Marangi GF, Tosi D, Morini S. Oestrogen receptor-alpha and -beta expression in breast implant capsules: experimental findings and clinical correlates. J Plast Reconstr Aesthet Surg 2014;67:308-15. [PMID: 24389289 DOI: 10.1016/j.bjps.2013.12.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
30 Schirmer JH, Both M, Moosig F. [Chronic periaortitis]. Internist (Berl) 2013;54:1419-20, 1422, 1424-6. [PMID: 24253388 DOI: 10.1007/s00108-013-3297-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Blatt AE, Liebman SE. Drug Induced Acute Kidney Injury. Hospital Medicine Clinics 2013;2:e525-41. [DOI: 10.1016/j.ehmc.2013.04.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Caiafa RO, Vinuesa AS, Izquierdo RS, Brufau BP, Ayuso Colella JR, Molina CN. Retroperitoneal Fibrosis: Role of Imaging in Diagnosis and Follow-up. RadioGraphics 2013;33:535-52. [DOI: 10.1148/rg.332125085] [Cited by in Crossref: 69] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
33 Bjorndalen H, Hastings RA. Ureteric obstruction secondary to retroperitoneal fibrosis leading to acute kidney injury. BMJ Case Rep 2013;2013:bcr2012008093. [PMID: 23389719 DOI: 10.1136/bcr-2012-008093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Brandt AS, Kamper L, Kukuk S, Piroth W, Haage P, Roth S. An aid to decision-making in therapy of retroperitoneal fibrosis: dynamic enhancement analysis of gadolinium MRI. J Clin Med Res 2013;5:49-56. [PMID: 23390476 DOI: 10.4021/jocmr1254e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
35 Sah RP, Chari ST. Overview. Autoimmune (IgG4-related) Pancreatitis and Cholangitis 2013. [DOI: 10.1007/978-1-4419-6430-4_17] [Reference Citation Analysis]
36 Gómez García I, Sánchez Castaño A, Romero Molina M, Rubio Hidalgo E, García Betancourth N, Labra González R, Sampietro Crespo A, Álvarez Fernández F, Flores Herrero Á, Gómez Rodríguez A. Retroperitoneal fibrosis: single-centre experience from 1992 to 2010, current status of knowledge and review of the international literature. Scand J Urol 2013;47:370-7. [PMID: 23206245 DOI: 10.3109/00365599.2012.747564] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
37 Rapacciuolo A, De Angelis MC, di Pietro E, Puglia R, Di Tommaso E, Ruggiero D, Amato B, Iannelli G. Percutaneous treatment of a aorto-caval fistula in a old high risk patient. BMC Surg 2012;12 Suppl 1:S32. [PMID: 23173555 DOI: 10.1186/1471-2482-12-S1-S32] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
38 Naderi AA, Houston BA, Sperati CJ. All wrapped up and nowhere to flow. Am J Med 2012;125:876-9. [PMID: 22682790 DOI: 10.1016/j.amjmed.2012.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Cope G. Disease profile: idiopathic retroperitoneal fibrosis. Journal of Renal Nursing 2012;4:188-190. [DOI: 10.12968/jorn.2012.4.4.188] [Reference Citation Analysis]
40 Kollert F, Binder M, Probst C, Uhl M, Zirlik A, Kayser G, Voll RE, Peter HH, Zissel G, Prasse A, Warnatz K. CCL18 -- potential biomarker of fibroinflammatory activity in chronic periaortitis. J Rheumatol 2012;39:1407-12. [PMID: 22589264 DOI: 10.3899/jrheum.111143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
41 Sampert C, Lowichik A, Rollins M, Inman CJ, Bohnsack J, Pohl JF. Sclerosing mesenteritis in a child with celiac disease. J Pediatr Gastroenterol Nutr. 2011;53:688-690. [PMID: 21572343 DOI: 10.1097/mpg.0b013e3182238113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
42 Bertagna F, Treglia G, Leccisotti L, Bosio G, Motta F, Giordano A, Giubbini R. [¹⁸F]FDG-PET/CT in patients affected by retroperitoneal fibrosis: a bicentric experience. Jpn J Radiol 2012;30:415-21. [PMID: 22421932 DOI: 10.1007/s11604-012-0066-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
43 Maturen KE, Sundaram B, Marder W, Swartz RD. Coronary Artery Involvement in Idiopathic Retroperitoneal Fibrosis: Computed Tomographic Findings. Journal of Thoracic Imaging 2012;27:W35-7. [DOI: 10.1097/rti.0b013e318213bcad] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
44 Sánchez-garcía M, Blanco-molina Á, Gallego de la Sacristana Á, Ogea J. Un nuevo abordaje terapéutico: remisión de las enfermedades fibrosantes tras la administración de bolos de metilprednisolona a altas dosis. Revista Clínica Española 2012;212:157-9. [DOI: 10.1016/j.rce.2011.05.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Sopel M, Falkenham A, Oxner A, Ma I, Lee TD, Légaré JF. Fibroblast progenitor cells are recruited into the myocardium prior to the development of myocardial fibrosis. Int J Exp Pathol 2012;93:115-24. [PMID: 22225615 DOI: 10.1111/j.1365-2613.2011.00797.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
46 Zeidel ML. Obstructive Uropathy. Goldman's Cecil Medicine. Elsevier; 2012. pp. 776-80. [DOI: 10.1016/b978-1-4377-1604-7.00125-1] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
47 Sibbitt WL. Idiopathic Multifocal Fibrosclerosis. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00284-0] [Reference Citation Analysis]
48 Muskardin TW, Gertner E. A 45-year-old man with flank pain and inability to ejaculate. Arthritis Care Res (Hoboken) 2012;64:616-22. [PMID: 22162419 DOI: 10.1002/acr.21567] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Székely H, Hagymási K, Sápi Z, Hartmann E, Mihály E, Muzes G, Tulassay Z. [Idiopathic retroperitoneal fibrosis. Pitfalls and challenges--experience with two cases]. Orv Hetil 2011;152:1818-26. [PMID: 22011369 DOI: 10.1556/OH.2011.29234] [Reference Citation Analysis]
50 Mi S, Li Z, Yang HZ, Liu H, Wang JP, Ma YG, Wang XX, Liu HZ, Sun W, Hu ZW. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J Immunol. 2011;187:3003-3014. [PMID: 21841134 DOI: 10.4049/jimmunol.1004081] [Cited by in Crossref: 251] [Cited by in F6Publishing: 262] [Article Influence: 22.8] [Reference Citation Analysis]
51 Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011;86:297-303. [PMID: 21454732 DOI: 10.4065/mcp.2010.0663] [Cited by in Crossref: 87] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
52 Kasper B, Ströbel P, Hohenberger P. Desmoid tumors: clinical features and treatment options for advanced disease. Oncologist. 2011;16:682-693. [PMID: 21478276 DOI: 10.1634/theoncologist.2010-0281] [Cited by in Crossref: 166] [Cited by in F6Publishing: 180] [Article Influence: 15.1] [Reference Citation Analysis]
53 Brandt A, Kamper L, Kukuk S, Haage P, Roth S. Associated Findings and Complications of Retroperitoneal Fibrosis in 204 Patients: Results of a Urological Registry. Journal of Urology 2011;185:526-31. [DOI: 10.1016/j.juro.2010.09.105] [Cited by in Crossref: 41] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
54 Teitelbaum I, Liebman S. Urinary Tract Obstruction. Textbook of Critical Care 2011. [DOI: 10.1016/b978-1-4377-1367-1.00116-6] [Reference Citation Analysis]
55 Franzen D, Brochhagen H, Benenson E. Immunosuppressive therapy in idiopathic multifocal fibrosis. A case report. OJIM 2011;01:9-13. [DOI: 10.4236/ojim.2011.12004] [Reference Citation Analysis]
56 . Current world literature. Curr Opin Rheumatol 2011;23:125-30. [PMID: 21124095 DOI: 10.1097/BOR.0b013e3283422cce] [Reference Citation Analysis]
57 Gil A, Ofer Y, Yigla M, Goralnik L, Meretyk S, Assady S. Obstructive uropathy caused by retroperitoneal fibrosis presents as a late manifestation of sarcoidosis. Renal Failure 2010;32:1118-20. [DOI: 10.3109/0886022x.2010.510612] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
58 de Socio G, Verrecchia E, Fonnesu C, Giovinale M, Gasbarrini GB, Manna R. Effectiveness of Colchicine Therapy in 4 Cases of Retroperitoneal Fibrosis Associated with Autoinflammatory Diseases. J Rheumatol 2010;37:1971-2. [DOI: 10.3899/jrheum.100352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
59 Paetzold S, Gary T, Hafner F, Brodmann M. Thrombosis of the inferior vena cava related to Ormond's disease. Clin Rheumatol 2013;32:67-70. [DOI: 10.1007/s10067-010-1456-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
60 Quaia E, Martingano P, Cavallaro M. Obstructive Uropathy, Pyonephrosis, and Reflux Nephropathy in Adults. Radiological Imaging of the Kidney 2010. [DOI: 10.1007/978-3-540-87597-0_14] [Reference Citation Analysis]